<p><b>*</b> Adjusted for age, sex and the time-dependent variables type of renal replacement therapy, C-reactive protein, albumin and hemoglobin.</p><p>Association between iron supplementation and all-cause mortality in patients with diabetes mellitus and without diabetes mellitus using time-dependent Cox proportional hazards models<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0114144#nt113" target="_blank">*</a></sup>.</p
[[abstract]]BACKGROUND: A risk/benefit analysis of iron supplementation in pre-dialysis advanced chr...
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
OBJECTIVEdTo investigate the impact of iron status on survival in patients with type 2 diabetes and ...
<p><b>*</b> Adjusted for age, sex, diabetes mellitus and the time-dependent variables type of renal ...
<div><p>Background</p><p>Studies on the association between iron supplementation and mortality in di...
Studies on the association between iron supplementation and mortality in dialysis patients are rare ...
<p>Shown for each model are estimated HRs for the linear component of the non-linear P-spline and HR...
The independent association between the indices of iron stores or administered intravenous iron, bot...
<p><sup>a</sup>Adjusted for age, gender, diabetes mellitus, previous cardiovascular disease history,...
<p>Hazard ratios and 95% confidence intervals (CIs) were derived from Cox regression analysis with i...
Background\ud Diabetes is the most common risk factor for end-stage renal disease (ESRD) and has bee...
Table S1. Quartiles according to baseline SF and TSAT levels in the general population and stratifie...
Background and objectives Clinical trials assessing effects of larger cumulative iron exposure with ...
<p>Adjusted for age, sex, time-dependent type of renal replacement therapy, diabetes, time-dependent...
OBJECTIVES: Data have indicated low to non-existent increased mortality risk for individuals with pr...
[[abstract]]BACKGROUND: A risk/benefit analysis of iron supplementation in pre-dialysis advanced chr...
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
OBJECTIVEdTo investigate the impact of iron status on survival in patients with type 2 diabetes and ...
<p><b>*</b> Adjusted for age, sex, diabetes mellitus and the time-dependent variables type of renal ...
<div><p>Background</p><p>Studies on the association between iron supplementation and mortality in di...
Studies on the association between iron supplementation and mortality in dialysis patients are rare ...
<p>Shown for each model are estimated HRs for the linear component of the non-linear P-spline and HR...
The independent association between the indices of iron stores or administered intravenous iron, bot...
<p><sup>a</sup>Adjusted for age, gender, diabetes mellitus, previous cardiovascular disease history,...
<p>Hazard ratios and 95% confidence intervals (CIs) were derived from Cox regression analysis with i...
Background\ud Diabetes is the most common risk factor for end-stage renal disease (ESRD) and has bee...
Table S1. Quartiles according to baseline SF and TSAT levels in the general population and stratifie...
Background and objectives Clinical trials assessing effects of larger cumulative iron exposure with ...
<p>Adjusted for age, sex, time-dependent type of renal replacement therapy, diabetes, time-dependent...
OBJECTIVES: Data have indicated low to non-existent increased mortality risk for individuals with pr...
[[abstract]]BACKGROUND: A risk/benefit analysis of iron supplementation in pre-dialysis advanced chr...
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
OBJECTIVEdTo investigate the impact of iron status on survival in patients with type 2 diabetes and ...